General Medical Council
Analysis
General Medical Council is a registered charity in England and Wales, based in London. It was registered in November 2001, 25 years ago. Its declared purposes cover education/training and the advancement of health or saving of lives, which this site groups under health and saving lives. It says it provides services, provides advocacy/advice/information and sponsors or undertakes research.
In the financial year ending December 2025, General Medical Council reported income of £171.5m and spending of £160.1m, spending 93% of its income. Across the 5 years on record, from December 2021 to December 2025, income grew from £122.3m to £171.5m (+40%), an average of +8.8% a year. Over the whole period it spent 96% of the income it received.
Among 24,651 England and Wales charities whose main cause is health and saving lives and that reported income, General Medical Council sits at the 100th percentile: it is one of the largest 1% in its cause. Against every charity in England and Wales with reported income it ranks in the 100th percentile. Charities of a similar size with the same main cause include The Royal British Legion (£168.5m), Ubs Optimus Foundation UK (£178.2m) and The National Association of Citizens Advice Bureaux (£167.8m).
In its latest detailed accounts, income came from charitable activities 97% and investments 1.3%. Charitable activities took 97% of spending and raising funds 0.4%. Reserves of £74.8m would cover about 5 months of spending at that rate. It employed 1,753 people.
Income and spending
Where the income comes from
- Charitable activities 97%
- Trading 0.4%
- Investments 1.3%
- Other 1.3%
In the charity's own words
We are an independent organisation that helps to protect patients and improve medical practice across the UK.
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| The Royal British Legion | London | £168.5m |
| Ubs Optimus Foundation UK | London | £178.2m |
| The National Association of Citizens Advice Bureaux | London | £167.8m |
| Genome Research Limited | Saffron Walden | £180.3m |